healthcare professional for medical advice
mild hair loss
short term use of oral contraceptive
relative excess
edema
hepatocellular carcinoma in the united state
several non contraceptive health benefit
combine oral contraceptive on the risk of cervical adenocarcinoma
risk of gallbladder disease
cardiovascular
venous thromboembolism
pulmonary embolism
oral contraceptive
case of fatal pulmonary venooclusive disease
cough of blood
iron deficiency anemia
rash
dysmenorrhea
estrogen in oral contraceptive combination
use of oral contraceptive combination
difficulty breathing
complex alteration in plasma lipid profile
speech
world health organization committee
spot
overall association between oral contraceptive use
progestin component of these formulation
association between oral contraceptive use
nervousness
woman
available oral contraceptive combination
weakness
ethinyl estradiol
available preparation
chest pain
vomit
change in secretion
manufacturer of oral contraceptive product
oral contraceptive use
gallbladder disease
double vision
arterial thrombosis
association
nausea
early investigation of woman
nervous system
fatiguehair
association with oral contraceptive
investigator
risk of epithelial ovarian cancer
yellow of the skin
absent menstrual period
hive
oily skinbreast tendernessdepressiontiredness
tenderness
benefit
other investigator
recur headache
myocardial infarction
dizziness
breast lump
cardiovascular system
specific group of woman
tightness in the chest
ovarian cancer
glucose tolerance
severe vaginal bleeding
public health importance in the united state
vision change
possible relationship between the use of oral contraceptive
most woman
vaginal spot
swell of the finger
depression
vaginal irritation
first several cycle of oral contraceptive use
older formulation
appetiteweight
hepatitis b virus infection
heaviness
exogenous estrogen
protection against ovarian cancer
vascular thrombosis
tenderness in the stomach
case of oral contraceptive induce systemic lupus erythematosus
breast discharge
detailed information
mood change
number of investigation
cause
large number of confounding factor
higher risk for endometrial carcinoma than other woman
leg
neoplasm of the uterine cervix
confusion
well differentiate hepatocellular carcinoma
increase ldl cholesterol level
breast tenderness
liver cell adenoma
protection
careful review of a woman
incidence of hospitalization for pelvic inflammatory disease
exist cancer
geographic tongue
severe lipidemia
progestin in a
potent progestin
committee of the world health organization
alteration in lipid profile
exogenous progestin
termination
long term risk for mortality
antiestrogen
use of oral contraceptive
smoke
epidermoid carcinoma
nauseaheadachemelasmahypertensionbreast tendernessedemaestrogen deficiency
significant blood pressure increase
tongue
leg pain
variation in the hormonal content of oral contraceptive
use of exogenous estrogen
swell of the mouth
breakthrough bleeding
acne
cholesterol level
persistent vaginal spot
non hormonal cause of such bleeding
relative risk of hepatocellular carcinoma
dark urine
malignant neoplasm
cardiovascular risk factor before a decision
late breakthrough bleedingamenorrheahypermenorrheaestrogen
risk of thromboembolism
gaincholestatic jaundiceprogestin deficiency
nulliparous woman
case of oral contraceptive induce esophageal ulceration
woman on oral contraceptive combination product
contraindication
conception delay
eye
bleedingincreased spottinghypomenorrhea
investigation into the epidemiology of this neoplasm
unusual tiredness
addition
observe association
faint
development of new case of cancer
pelvic inflammatory disease in woman
hepatocellular carcinoma
young woman
ovarian cyst
ankle
precipitation of panic disorder
one side weakness
risk of ovarian cancer
calf
headache
risk of breast cancer
pelvic inflammatory disease
increase risk
give product
early mid cycle breakthrough
mcg
deficiency of the estrogen
potency of the specific estrogen
underlie
other western nation
other risk factor
such woman
possible relationship between oral contraceptive use
fda
change in weight
treated woman
bloat
breast cancer
oral contraceptive combination
stroke
same committee
case of retinal thrombosis
development of breast cancer
insufficient datum
strong association between oral contraceptive use
exist
hdl
stomach cramp
intrahepatic cholestasis
sudden severe headache
estrogen
hepatic granuloma
weak association between long term use of oral contraceptive
bias
hypertension
change in contact lens tolerance
ectopic pregnancy
exist vascular disease
face
numbness of a arm
hematologic concern
risk of endometrial cancer
change in appetite
family history of breast cancer
severity
migraine
long term use
adenocarcinoma of the cervix
severe pain
endometrial carcinoma
chorea
oral contraceptive user
lip
sudden vision loss
accelerate growth
finding
woman with a history of previous thrombotic disease
recent large investigation of woman
young diabetic woman
firm conclusion
deficiency of these component
unusual hoarseness
fever
preexist systemic disease
itch
focal nodular hyperplasia
swell
underlie cardiovascular disease
woman experience oligomenorrhea
hand
enlargement
relative amount
case of venous thrombosis
previous thrombotic disease
discharge
norgestrel
preexist
thrombotic stroke
long term use of oral contraceptive
shortness of breath
carbohydrate metabolism
lower risk
hepatic hemangioma
change in the amount of urine
menstrual irregularity
amenorrhea
progestin
cause favorable change in lipid profile
develop country
pale stool
increase risk of dysplasia
actual number of case of liver cancer in the united state